Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Hologic Stock Quote

Hologic (NASDAQ: HOLX)

$74.92
(-0.3%)
-$0.19
Price as of April 17, 2024, 4:00 p.m. ET

Hologic Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
HOLX -9.20% +72.63% +11.53% +3,034%
S&P +20.88% +72.88% +11.56% +1,409%

Hologic Company Info

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment consists of products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

News & Analysis

The Fool has written over 100 articles on Hologic.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.